Dr. Nandi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave N
Worcester, MA 01655Phone+1 508-334-3550Fax+1 774-442-6715
Summary
- I am currently fellow in a Hematology/Oncology at the University of Massachusetts.
Education & Training
- UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 2020 - 2023
- AtlantiCare Regional Medical CenterResidency, Internal Medicine, 2017 - 2020
- American University of Antigua College of MedicineClass of 2017
- Rutgers UniversityCell Biology and Neuroscience
Certifications & Licensure
- GA State Medical License 2024 - 2025
- NJ State Medical License 2018 - 2025
- MA State Medical License 2020 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
Journal Articles
- Ibuprofen-induced thrombotic thrombocytopenic purpuraBenmoussa. J, MD, Chevenon. M, MSc, Nandi.M, BSc, Nfonoyim. J, MD, Forlenza T, MD, The American Journal of Emergency Medicine, Volume 34, Issue 5, 942.e5 - 942.e7.
- A Fatal Case of Primary Amebic Meningoencephalitis from Recreational Waters” Department of Neurocritical Care MedicineMinesh Nandi M.D, Saif Faeik M.D, Manish Trivedi M.D, Edward Hamaty, Jr D.O, Critical Care Medicne
- A Rare Case of Intracranial Germinoma in a 21-year-old Romanian MaleMinesh Nandi, Case Report in Oncological Medicine, 1/4/2020
- Join now to see all
Abstracts/Posters
- Somatostatin Receptor Activation by Agonist-like Antibodies can Reverse miR-200c/ZEB1 Dependent Cell Dedifferentiation and Increase Cell Death in Neuroendocrine Tumor ...Nandi M, North American Neuroendocrine Tumor Society
- Anti-SSTR antibodies can reverse neuroendocrine tumor cellular dedifferentiation induced by neutralizing EMT regulator miR- 200c in pancreatic neuroendocrine tumor BON...Leu F, Nandi M, C Wong, Pancreas, 4/15/2010
Committees
- Chair, Research Committee 2018 - Present
- Associate Member, Ethics Committee
- Associate Member, Community Engagement
Research History
- Research Associate Scientist IIIR&D of novel therapeutic antibody-based treatment for neuroendocrine and pancreatic tumors.Carried out receptor functioning studies using multiple techniques including live cell imaging, pseudo-confocal microscopy, use of nanocrystals to determine the functionality of the monoclonal antibody
Professional Memberships
- Member
- Member
- Member
Other Languages
- Hindi, Gujarati
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: